It’s Time to Rein In Dangerous “Bad Drug” Ads
As one of the many physicians who has seen patients harmed by misleading television advertisements, I urge policymakers to make this the year they rein in “bad drug” ads.
Striving for Patient-Centered Diabetes Care
The pandemic has forced many Americans to re-examine their approach to life’s challenges and identify ways to be more efficient in changing times. The same should apply to treating people who live with diabetes.
Capping Insulin Co-pays Could Help Fight COVID-19
I have been a doctor for 35 years and I have seen a lot of crises. But I have never seen the country’s health care resources strained the way they are right now.
New Label Could Fix Medicaid’s Insulin Pen Misstep
An updated label from the Food and Drug Administration now discourages pharmacies from dividing prepackaged cartons into individual pens before distributing.
Can ICER Put a Value on Diabetes Management?
A new report from the Institute for Clinical and Economic Review says oral semaglutide treatment for people with Type 2 diabetes isn’t cost effective.
Uncertainty Plagues ICER Report on Type 2 Diabetes
Just one thing stands between some Type 2 diabetes patients and disease management: a dislike of needles.
Diabetes, Deductibles & the IRS
People living with diabetes might soon have better access to care thanks to an unlikely source: the Internal Revenue Service.
Medicaid Rule Undermines Insulin Access
Medicaid’s efforts to save a buck could cost diabetes patients in a big way.
